Clinical Trials for Refractory Follicular Lymphoma

Find clinical trials for refractory follicular lymphoma. Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

NCT ID: NCT05828589

This clinical trial is studying a new drug called BGB-21447, which is designed to help people with certain types of cancer affecting B-cells, such as non-Hodgkin lymphoma and chronic lymphocytic le...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Rozzano, , Italy +44 more

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

NCT ID: NCT04224493

This clinical trial is testing a new treatment combination for adults with relapsed or refractory follicular lymphoma, a type of blood cancer that has returned or is resistant to previous therapies...

Recruiting

Phase: PHASE3 Type: interventional Locations: Ann Arbor, Michigan, United States, Chicago, Illinois, United States +311 more

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

NCT ID: NCT05627245

This clinical trial is investigating the safety and effectiveness of two anti-cancer drugs, tazemetostat and belinostat, for patients with certain types of lymphomas that have come back after treat...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Oklahoma City, Oklahoma, United States +8 more

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT ID: NCT06712810

This clinical trial is studying a new medication called Q702 to see how safe it is and how well it works for people with certain types of blood cancers, known as hematologic malignancies. These can...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

NCT ID: NCT03147885

This clinical trial is studying a new treatment approach for patients with advanced B-cell non-Hodgkin lymphoma, including types like diffuse large B-cell lymphoma and others. The trial combines a ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, La Jolla, California, United States

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

NCT ID: NCT06948786

The PROMOTE-FL trial is a clinical study looking at two medications, pirtobrutinib and mosunetuzumab, to see how well they work together in treating patients with grades 1-3a follicular lymphoma (F...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

NCT ID: NCT04587687

This clinical trial is studying the combination of two treatments, brentuximab vedotin and bendamustine, to see how effective they are for patients with follicular lymphoma that has either returned...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

NCT ID: NCT05453396

This clinical trial is studying a new treatment called loncastuximab tesirine for patients with specific types of B-cell cancers that have either come back after previous treatments or did not resp...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT ID: NCT04195633

This clinical trial is studying a new treatment approach for patients with various types of blood cancers, such as acute leukemia and lymphoma. The treatment combines a donor stem cell transplant w...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States

A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic Mutation

NCT ID: NCT06068881

This clinical trial is looking at a medication called tazemetostat to see how well it works and how safe it is for adults with a type of blood cancer called follicular lymphoma. Specifically, it fo...

Not yet recruiting

Phase: PHASE2 Type: interventional

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

NCT ID: NCT06191887

This clinical trial is investigating a new treatment approach for patients with certain types of blood cancers that have returned after treatment or have not responded well to previous therapies. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

NCT ID: NCT05848765

The REFRACT clinical trial is designed to explore new treatment options for patients with relapsed or refractory follicular lymphoma, a type of blood cancer. The goal is to see if these new therapi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Leeds, , United Kingdom, London, , United Kingdom +23 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions